ARCHIVES

Doubling Budget For NSF High Priority For FASEB.

This article is from The Cancer Letter archive.

Vol. 27 No. 16 | April 20, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

St. John’s Wort Not Indicated For Patients On Irinotecan

May 31, 2002

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

NCI Bypass Budget Seeks $3.6 Billion for Fiscal 1995

October 1, 1993

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996